Health
New Alzheimer’s drug aducanumab is dividing doctors and patients, as the TGA weighs up its risk-benefit profile – ABC News
The first new Alzheimer’s drug approved by US regulators in almost two decades is generating global interest and global controversy….
After a decades-long career as a biology teacher, John Rodgers applies the strict logic of a scientist to answer tough questions.
So, when it comes to his mortality, he is equally rational.
“I either want it to end quickly or get better,” he said.
Key points:
…
Continue Reading
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General19 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor
-
Noosa News17 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station